Strides Arcolab
BSE: 532531|NSE: STAR|ISIN: INE939A01011|SECTOR: Pharmaceuticals
LIVE
BSE
Feb 10, 15:54
541.25
-4.8 (-0.88%)VOLUME 11,820
LIVE
NSE
Feb 10, 17:00
543.50
-3.7 (-0.68%) VOLUME 91,359
Quarterly Results of Strides Arcolab |
------------------- in Rs. Cr. ------------------- |
 | ||||||||||
|
||||||||||
| Sep '11 | Jun '11 | Mar '11 | Dec '10 | Sep '10 | ||||||
|
||||||||||
| Sales Turnover | 196.98 | 200.93 | 127.94 | 141.30 | 135.88 | |||||
| Other Income | -- | -- | -- | -0.62 | -- | |||||
| Total Income | 196.98 | 200.93 | 127.94 | 140.68 | 135.88 | |||||
| Total Expenses | 191.48 | 161.75 | 106.76 | 116.97 | 115.22 | |||||
| Operating Profit | 5.50 | 39.18 | 21.18 | 24.33 | 20.66 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -50.85 | 10.79 | 17.23 | 44.21 | 14.75 | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 5.50 | 39.18 | 21.18 | 23.71 | 20.66 | |||||
| Interest | 20.84 | 20.92 | 18.36 | -16.20 | 21.27 | |||||
| PBDT | -66.18 | 23.65 | 20.05 | 84.12 | 14.14 | |||||
| Depreciation | 4.01 | 4.04 | 3.86 | 4.69 | 3.49 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | -70.19 | 19.61 | 16.19 | 79.43 | 10.65 | |||||
| Tax | -5.00 | 5.00 | 3.45 | 13.00 | -- | |||||
| Net Profit | -65.19 | 14.61 | 12.74 | 66.43 | 10.65 | |||||
| Prior Years Income/Expenses | -- | -- | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share | -- | 2.52 | 2.21 | 11.50 | 2.27 | |||||
| Book Value | -- | -- | -- | -- | -- | |||||
| Equity | 58.37 | 58.02 | 57.77 | 57.74 | 46.92 | |||||
| Reserves | -- | -- | -- | -- | -- | |||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |||||
| ||||||||||
| Source : Dion Global Solutions Limited | ||||||||||
| Explore Strides Arcolab connections | ||||||||||
| ||||||||||
Results of Strides Arcolab
- News
- Results
- Estimates
- Analysis
Results of Pharmaceuticals Sector
- News
- Results
- Estimates
- Analysis
Quick Links for stridesarcolab
|
Related Searches
stridesarcolab Stock Price, Strides%20Arcolab Stock Quote, Strides%20Arcolab Results , Strides%20Arcolab News ..
More »
Follow moneycontrol.com
Explore Moneycontrol
Mutual Funds
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
News |
Markets |
IPO |
Technicals |
Mutual Fund |
Commodities |
Best Portfolio Manager |
Bse Sensex |
Bombay Stock Exchange |
Share Market Live |
Recession 2011 |
Commodities Price |
Silver Price/Rate in India |
Gold Price/Rate in India |
Crude Oil |
USD to INR |
National Stock Exchange |
Bank Fixed Deposits |
Company Fixed Deposits |
Small Savings Schemes |
Property rates in India |
| Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide |
Bigg Boss Season 5
| History India | Davos
| Uninor | Aurobindo Pharma | Indian Space Research Organisation | Vodafone Essar | Bonus share | Suzlon Energy | Etisalat | Securities and Exchange Board of India | State Bank of India | Mark Zuckerberg
| Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide |
Bigg Boss Season 5
| History India | Davos
| Uninor | Aurobindo Pharma | Indian Space Research Organisation | Vodafone Essar | Bonus share | Suzlon Energy | Etisalat | Securities and Exchange Board of India | State Bank of India | Mark Zuckerberg
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Statement | Terms of Use | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.